VIDEO: Innovation in an uncertain world

March 21, 2017 Christoph Graener

 

In the best of times, biotech innovation is full of uncertainty. But today’s political, regulatory, and social upheaval have added more complexity than usual. How are cutting-edge biotech companies trying to compete in a global marketplace dealing with drug-price anger, science skepticism, and policies to close borders and protect jobs.


 

Moderator: Alex Lash – Xconomy

  • Annie De Groot – EpiVax
  • Ji Li – BeiGene
  • Kevin Sin – Genentech Partnering

Click here to read discussion highlights 


Rise to new heights at our next event, BioPharm America. We offer powerful opportunities for you to network with the right partners and bring together hundreds of the world’s most innovative leaders across biotech, finance and pharma for high-level networking, pre-scheduled partnering meetings, strategic panel discussions and more.

 

 

Previous Video
BIO-Europe Spring® 2017: Imanova trims Phase I and IIa trial timelines and costs
BIO-Europe Spring® 2017: Imanova trims Phase I and IIa trial timelines and costs

Dr. Kevin Cox, CEO of Imanova, the UK-based translational biomedical imaging company, explains to Scrip’s M...

Next Video
BIO-Europe Spring® 2017: Avir BD execs on innovative meds for Canadians
BIO-Europe Spring® 2017: Avir BD execs on innovative meds for Canadians

Located in Quebec, Canada, Avir Pharma, a specialty pharma company, is part of the Laboratoire Riva group. ...